Patient Care

Samer Traboulsi, MD

Clinical Assistant Professor
Department of Surgery
Division of Urology

Dr. Samer Traboulsi is a Clinical Assistant Professor in the Division of Urology at the LAU Gilbert and Rose-Marie Chagoury School of Medicine and medical centers. He received his medical degree in 2008 and completed his residency in Urology in 2014 at the American University of Beirut. Dr. Traboulsi then traveled to Canada where he obtained a two-year post-doctoral research fellowship in Biology and Therapy of Urothelial Carcinoma at McGill University in Montreal. He subsequently joined the University of Montreal in 2016 where he completed a two-year clinical fellowship in Urologic Oncology; there he was involved in major therapeutic trials for prostate cancer, whose results have recently been published. Subsequently, from 2018-2019, he pursued a fellowship in Minimally Invasive and Robotic Surgery through a joint program at McGill University and the University of Montreal. 

Dr. Traboulsi is the author of more than 16 peer-reviewed publications and two book chapters. He is also a reviewer for several  international scientific journals including the Journal of Urology,  the Gold Journal and the Canadian Urological Association Journal. Dr. Traboulsi furthermore is the recipient of the University of Montreal Research Center Scholarship in 2016 and 2017.

His clinical and surgical focus are open and minimally invasive treatment of urologic malignancies in addition to benign genitourinary diseases. Dr. Traboulsi will be covering our main clinical campus at LAU Medical Center-Rizk Hospital, as well as the new LAU Medical Center- Saint John’s Hospital in Jounieh. 

Selected Publications

  1. Traboulsi SL, Nguyen DD, Zakaria AS et al. Functional and perioperative outcomes in elderly men after robotic-assisted radical prostatectomy for prostate cancer. World J Urol (2020)
  2. Traboulsi SL, Saad F. Management of nonmetastatic castration-resistant prostate cancer. Curr Opin Support Palliat Care (2018 Sep) 12(3):366-371 
  3. Traboulsi SL, Saad F. The role of bone-targeted therapies for prostate cancer in 2017. Curr Opin Support Palliat Care (2017) 11(3):216-224
  4. Traboulsi SL, Brimo F, Yang Y et al. Pathology review impacts clinical management of patients with T1‒T2 bladder cancer. Can Urol Assoc J (2017) 11(6):188-193
  5. Kassouf W, Traboulsi SL, Schmitz-Dräger B et al. Follow-up in non-muscle invasive bladder cancer – IBCN recommendations. Urol Oncol Semin Orig Investig(2016) 34:460-468
  6. Traboulsi SL, Witjes JA, Kassouf W. Contemporary management of primary distal urethral cancer. Urol Clin North Am (2016 Nov) 43(4):493-503
  7. Duivenvoorden WC, Daneshmand S, Canter D, Lotan Y et al. Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy. J Urol (2016) 196(6):1627-1633
  8. Wang HJ, Solanki S, Traboulsi SL et al. Neoadjuvant chemotherapy–related histologic changes in radical cystectomy: Assessment accuracy and prediction of response. Hum Pathol (2016) 53:35-40
  9. Kassouf W, Traboulsi SL, Kulkarni GS et al. CUA guidelines on the management of non-muscle invasive bladder cancer. Can Urol Assoc J (2015) 9(9-10):E690-E704
  10. Florianova L, Xu B, Traboulsi S et al. Evaluation of RNA-binding motif protein 3 expression in urothelial carcinoma of the bladder: An immunohistochemical study. World J Surg Oncol (2015 Nov) 13:317
View Dr. Traboulsi’s publications on Pubmed (search terms: Traboulsi, Samer).
 

Professional and Research Interests

Education and Training

Professional Organizations and Memberships

 

Keywords

Benign bladder diseases, benign prostate diseases, male infertility, priapism, urinary obstruction, urinary stone disease, urologic infections, UTI, sexually transmitted diseases, STD, vasectomy, adrenal cancer, bladder cancer, kidney cancer, penile cancer, prostate cancer, testicular cancer, ureteral cancer